Too Crowded? ImmuneOncia Looks To Niches To Challenge PD-L1 Space

Pursues Two-Track Strategy

different
ImmuneOncia's PD-L1 Strategy Aimed At Finding Niche • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia